Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
Queensland Health
QuintilesIMS
Cipla
Merck

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 6,017,762

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,017,762
Title: Cassette for the expression of an endothiapepsin precursor in Cryphonectria parasitica
Abstract:The present invention relates to a new cassette for the expression of an endothiapepsin precursor in Cryphonectria parasitica, to a strain of this species transformed with this cassette, to a process for preparing endothiapepsin using this strain and also to a process for preparing such a strain devoid of a dominant selection marker.
Inventor(s): Jara; Patrick (Castanet-Tolosan, FR), Legoux; Richard (Caraman, FR), Loison; Gerard (Toulouse, FR), Razanamparany; Voahangy (Toulouse, FR)
Assignee: Sanofi (Paris, FR) Elf Aquitaine (Courbevoie, FR)
Application Number:08/115,753
Patent Claims:see list of patent claims

Details for Patent 6,017,762

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Sanofi (Paris, FR) Elf Aquitaine (Courbevoie, FR) 2017-01-25 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Sanofi (Paris, FR) Elf Aquitaine (Courbevoie, FR) 2017-01-25 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Sanofi (Paris, FR) Elf Aquitaine (Courbevoie, FR) 2017-01-25 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
US Army
Healthtrust
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.